Best Agrolife Group, a frontrunner in innovative crop protection solutions, has received the regulatory approval of a patented herbicide “Shot Down” and the under-patent advanced insecticide “Bestman.”

This approval paves way for the company for launching these innovative products in Q4FY24. While “Bestman” will see traction in the Rabi season itself, “Shot Down” will see effective sale in the Kharif season.

These two new products align with Best Agrolife’s strategy of introducing at least 2-3 patented products annually, having already introduced Nemagen, Defender and Warden Extra in H1FY24. The company is confident that these innovative products will strengthen its market leadership and foster a sustainable revenue growth.

“Shot Down”, a proprietary herbicidal formulation combining Haloxyfop-R-methyl and Imazethapyr in a Microemulsion (ME) formulation, offers farmers a robust tool for controlling invasive weeds across groundnut and soybean crops.

This product targets a segment valued at approximately Rs 2,000 crores. Best Agrolife is targeting an initial revenue of Rs 70 crores from “Shot Down” in its first year of launch, and expects to grow sales to around Rs 300 crores over the next few years as it gains traction and popularity among groundnut and soybean farmers nationwide.

Also set to debut in early 2025, “Bestman” is an advanced insecticide blend of Fipronil, Abamectin and Tolfenpyrad in a suspension concentrate (SC) formulation. This under patent formulation provides effective control against multiple pests such as aphids, thrips, mites, and the notorious fruit borer. These pests are particularly challenging for chilli farmers and this product provides a single shot solution. Slated for introduction during the peak season for chilli crops, “Bestman” will help farmers derive higher yields.

With an estimated market segment size of Rs 3,000 crores in pest management solutions for chilli, cotton and vegetable crops, Best Agrolife anticipates sale of Rs 70 crores from “Bestman” within the launch year, with projected incremental growth of Rs 250 crores in the ensuing years.